Volume 88, special issue 7, Numéro spécial, Août 2001

L'Oxaliplatine

Oxaliplatin: perspectives and future developments (p.5-8)
Michel Marty, Paul-Henry Cottu, Florence Lerebours, Naima Bedairia, Hamid Hocini, Marc Espié

Oxaliplatin: a first DACH-platinum in oncology (p.9-13)
Abderrhamane Laadem, Esteban Cvitkovic

Pharmacokinetic properties of platinium derivatives (p.14-9)
Michèle Boisdron-Celle, Anne Lebouil, Pierre Allain, Erick Gamelin

Oxaliplatin in combination with 5-fluoro-uracil and folinic acid as treatment of metastatic colorectal cancer (p.20-5)
Thierry André, Christophe Louvet, Frédérique Maindrault-Goebel, Aimery de Gramont

Preclinical studies of oxaliplatin in combination chemotherapy (p.26-34)
Eric Raymond, Sandrine Faivre, Anne-Marie Coudray, Christophe Louvet, Christian Gespach

Oxaliplatin in combination with non fluoropyrimidine drugs in colorectal cancer (p.35-9)
Michel Ducreux, Karim Fizazi, Jean-François Seitz, Yves Becouarn, Jean-Pierre Armand

Clinical use of oxaliplatin in solid tumors (p.40-4)
François Goldwasser, Jean-Louis Misset

Oxaliplatin: safety profile in metastatic colorectal cancer (p.45-9)
Roland Bugat